Results 21 to 30 of about 39,764 (292)

Colitis Following Initiation of Sofosbuvir and Simeprevir for Genotype 1 Hepatitis C. [PDF]

open access: yes, 2015
Sofosbuvir and simeprevir are used for the treatment of chronic hepatitis C (HCV) genotype 1. Both drugs have been well-tolerated, with diarrhea noted in 6% cases with sofosbuvir, 16% with sofosbuvir plus simeprevir, and 0% with simeprevir.
Jakab, Simona   +4 more
core   +1 more source

Microscopic colitis: an update

open access: yesMedicine and Pharmacy Reports, 2022
Microscopic colitis (MC) is an inflammatory pathology of the bowel diagnosed predominantly in older patients. MC is a cause of chronic watery, non-bloody diarrhea, that affects the older patients, mostly women, and leads to impaired health-related quality of life. The diagnosis and treatment can be often difficult.
Fărcaş, Radu A.   +2 more
openaire   +3 more sources

Budesonide treatment for microscopic colitis from immune checkpoint inhibitors

open access: yesJournal for ImmunoTherapy of Cancer, 2019
Background Immune checkpoint inhibitors (CPIs) are effective against a variety of malignancies but can be limited by inflammatory toxicities such as enterocolitis. Enterocolitis is typically treated with systemically active glucocorticoids. Endoscopy can
Michael S. Hughes   +7 more
doaj   +1 more source

Lymphocytic Colitis in Nigeria: A Case Series

open access: yesThe Annals of African Surgery, 2021
The term “microscopic colitis” (MC) is used to describe a chronic inflammatory bowel disease that includes two main subtypes based on histopathologic features: collagenous and lymphocytic.
Aderemi Oluyemi   +3 more
doaj   +1 more source

Fibrotic and Vascular Remodelling of Colonic Wall in Patients with Active Ulcerative Colitis [PDF]

open access: yes, 2016
open16noIntestinal fibrosis is a complication of inflammatory bowel disease [IBD]. Although fibrostenosis is a rare event in ulcerative colitis [UC], there is evidence that a fibrotic rearrangement of the colon occurs in the later stages.
Bassotti, Gabrio   +15 more
core   +2 more sources

The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study [PDF]

open access: yes, 2013
<p>Introduction: Children presenting for the first time with inflammatory bowel disease (IBD) offer a unique opportunity to study aetiological agents before the confounders of treatment.
AJ Lastovica   +63 more
core   +4 more sources

The role of the novel Th17 cytokine IL-26 in intestinal inflammation [PDF]

open access: yes, 2008
Background and aims: Interleukin 26 (IL-26), a novel IL-10-like cytokine without a murine homologue, is expressed in T helper 1 (Th1) and Th17 cells. Currently, its function in human disease is completely unknown. The aim of this study was to analyse its
Auernhammer, Christoph J.   +7 more
core   +1 more source

PROTON-PUMP INHIBITORS ARE ASSOCIATED WITH AN INCREASED RISK OF MICROSCOPIC COLITIS: A POPULATION-BASED STUDY AND REVIEW OF THE LITERATURE [PDF]

open access: yesArquivos de Gastroenterologia
Background: Microscopic colitis is a relatively new diagnosis that was first described in the 1980s. Patients usually present with chronic watery and non-bloody diarrhea and are typically characterized by an unremarkable gross appearance of the colon on ...
Rashid ABDEL-RAZEQ   +10 more
doaj   +1 more source

Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation [PDF]

open access: yes, 2016
Although defects in intestinal barrier function are discussed as a key pathogenic factor in patients with inflammatory bowel diseases (IBD), the molecular pathways driving disease-specific alterations of intestinal epithelial cells (IECs) are largely ...
Alastair J.M. Watson   +27 more
core   +1 more source

Benign retroperitoneal schwannoma presenting as colitis: A case report [PDF]

open access: yes, 2007
We report a case of a patient presenting with clinical , radiological and endoscopic features of colitis due to a compressive left para-aortic mass.
Claes, Kathleen   +7 more
core   +2 more sources

Home - About - Disclaimer - Privacy